Obedience and motivation as mechanisms for adherence to medication: A study in obese type 2 diabetic patients

Patient Preference and Adherence

Volumn 5, Issue , 2011, Pages 523-531

  Reach, Gérard ^a  

^a AVICENNE HOSPITAL   (France)

Author keywords

Adherence; Compliance; Medication; Motivation; Obedience; Patience; Reactance; Seatbelt

Indexed keywords

HEMOGLOBIN A1C;

ACCURACY; ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; CONTROLLED STUDY; DIABETIC OBESITY; DISEASE ASSOCIATION; DOCTOR PATIENT RELATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MOTIVATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; PRESCRIPTION; QUESTIONNAIRE; SEATBELT;

EID: 84866117510     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S24518     Document Type: Article

References (45)

1. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;2:CD000011.
2. Lawrence DB, Ragucci KR, Long LB, Parris BS, Helfer LA. Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management program. J Manag Care Pharm. 2006;12(6):466-471.
3. Rozenfeld Y, Hunt JS, Plauschinat C, Wong KS. Oral antidiabetic medication adherence and glycemic control in managed care. Am J Manag Care. 2008;14(2):71-75.
4. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836-1841.
5. Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL. Prevalence and economic consequences of medication adherence in diabetes: a systematic literature review. Manag Care Interface. 2006;19(7):31-41.
6. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521-530.
7. Sabato E, editor. Adherence to Long Term Therapies-Evidence for Action. Geneva: World Health Organization; 2003.
8. Curtis JR, Xi J, Westfall AO, et al. Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis. Med Care. 2009;47(3):334-341.
9. Brookhart MA, Patrick AR, Dormuth C, et al. Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol. 2007;166(3):348-354.
10. Perros P, Deary IJ, Frier BM. Factors influencing preference of insulin regimen in people with type 1 (insulin-dependent) diabetes. Diabetes Res Clin Pract. 1998;39(1):23-29.
11. Solberg LI, Desai JR, O'Connor PJ, Bishop DB, Devlin HM. Diabetic patients who smoke: are they different? Ann Fam Med. 2004;2(1): 26-32.
12. Ahmed AT, Karter AJ, Liu J. Alcohol consumption is inversely associated with adherence to diabetes self-care behaviors. Diabet Med. 2006;23(7):795-802.
13. Berrigan D, Dodd K, Troiano RP, Krebs-Smith SM, Barbash RB. Patterns of health behavior in US adults. Prev Med. 2003;36(5):615-623.
14. Girerd X, Hanon O, Anagnostopoulos K, Ciupek C, Mourad JJ, Consoli S. Evaluation de l'observance du traitement antihypertenseur par un questionnaire: mise au point et utilisation dans un service spécialisé. [Assessment of antihypertensive compliance using a self-administered questionnaire: development and use in a hypertension clinic]. Presse Med. 2001;30(21):1044-1048. (French).
15. Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction. Psychol Rev. 1987;94(4):469-492.
16. Elster J. Strong Feelings, Emotions, Addiction and Human Behavior (Jean Nicod Lectures). Cambridge, MA: MIT Press; 2000.
17. Langlie JK. Interrelationships among preventive health behaviors: a test of competing hypotheses. Public Health Rep. 1979;94(3):216-225.
18. Williams AF, Wechsler H. Interrelationship of preventive actions in health and other areas. Health Serv Rep. 1972;87(10):969-976.
19. Mohamed N, Mohd Yusoff MF, Isah N, Othman I, Syed Rahim SA, Paiman N. Analysis of factors associated with seatbelt wearing among rear passengers in Malaysia. Int J Inj Contr Saf Promot. 2011;18(1): 3-10.
20. Gillespie GL, Al-Natour A, Marcum M, Sheehan H. The prevalence of seatbelt use among pediatric hospital workers. AAOHN J. 2010;58(11): 483-486.
21. Streff FM, Geller ES. Strategies for motivating safety belt use: the application of applied behavior analysis. Health Educ Res. 1986;1(1): 47-59.
22. Brehm JW. A Theory of Psychological Reactance. New York: Academic Press; 1966.
23. Fogarty JS. Reactance theory and patient noncompliance. Soc Sci Med. 1997;45(8):1277-1288.
24. Reach G. A novel conceptual framework for understanding adherence to long term therapies. Patient Prefer Adherence. 2008;2:7-19.
25. Reach G, Michault A, Bihan H, Paulino C, Cohen R, Le Clésiau H. Patients' impatience is an independent determinant of poor diabetes control. Diabetes Metab. May 6, 2011. [Epub ahead of print.]
26. Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15.
27. Morris AD, Boyle DI, McMahon AD, Greene SA, MacDonald TM, Newton RW. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/ MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit. Lancet. 1997;350(9090): 1505-1510.
28. Frederick S. Time preference and identity. In: Loewenstein G, Read D, Baumeister RF, editors. Time and Decision: Economic and Psychological Perspectives on Intertemporal Choice. New York: Russel Sage Foundation; 2003:89-113.
29. Reach G. Is there an impatience genotype leading to non-adherence to long term therapies? Diabetologia. 2010;53(8):1562-1567.
30. Christakou A, Brammer M, Rubia K. Maturation of limbic corticostriatal activation and connectivity associated with developmental changes in temporal discounting. Neuroimage. 2011;54(2):1344-1354.
31. Briesacher BA, Andrade SE, Fouayzi H, Chan KA. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008;28(4):437-443.
32. Lee R, Taira DA. Adherence to oral hypoglycemic agents in Hawaii. Prev Chronic Dis. 2005;2(2):A09.
33. Yang Y, Thumula V, Pace PF, Banahan BF 3rd, Wilkin NE, Lobb WB. High-risk diabetic patients in Medicare Part D programs: are they getting the recommended ACEI/ARB therapy? J Gen Intern Med. 2010;25(4): 298-304.
34. Zhu B, Zhao Z, McCollam P, et al. Factors associated with clopidogrel use, adherence, and persistence in patients with acute coronary syndromes undergoing percutaneous coronary intervention. Curr Med Res Opin. 2011;27(3):633-641.
35. Park DC, Hertzog C, Leventhal H, et al. Medication adherence in rheumatoid arthritis patients: older is wiser. J Am Geriatr Soc. 1999;47(2): 172-183.
36. Netelenbos JC, Geusens PP, Ypma G, Buijs SJ. Adherence and profile of non-persistence in patients treated for osteoporosis-a large-scale, long-term retrospective study in The Netherlands. Osteoporos Int. 2011; 22(5):1537-1546.
37. Asghari S, Courteau J, Drouin C, et al. Adherence to vascular protection drugs in diabetic patients in Quebec: a population-based analysis. Diab Vasc Dis Res. 2010;7(2):167-171.
38. Jansà M, Hernández C, Vidal M, et al. Multidimensional analysis of treatment adherence in patients with multiple chronic conditions. A cross-sectional study in a tertiary hospital. Patient Educ Couns. 2010; 81(2):161-168.
39. Lutfey KE, Ketcham JD. Patient and provider assessments of adherence and the sources of disparities: evidence from diabetes care. Health Serv Res. 2005;40(6 Pt 1):1803-1817.
40. Bader A, Kremer H, Erlich-Trungenberger I, et al. An adherence typology: coping, quality of life, and physical symptoms of people living with HIV/AIDS and their adherence to antiretroviral treatment. Med Sci Monit. 2006;12(12):CR493-CR500.
41. Lutfey KE, Wishner WJ. Beyond "compliance" is "adherence. " Improving the prospect of diabetes care. Diabetes Care. 1999;22(4):635-639.
42. Reach G. Obstacles to patient education in chronic diseases: a transtheoretical analysis. Patient Educ Couns. 2009;77(2):192-196.
43. Fogarty JS, Youngs GA Jr. Psychological reactance as a factor in patient noncompliance with medication taking: a field experiment. J Appl Soc Psychol. 2000;30(11):2365-2391.
44. Funnell MM, Anderson RM, Arnold MS, et al. Empowerment: an idea whose time has come in diabetes education. Diabetes Educ. 1991;17(1): 37-41.
45. Descartes R. [Passions de l'Ame] (1649), Passions of the Soul, In: Some Texts in Modern Philosophy. Available from: http://www.earlymoderntexts. com/pdfbits/despass1.pdf. Accessed October 4, 2011.